A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if BMS-582949 alone is an effective
treatment for moderate to severe psoriasis. The safety of the drug and the effectiveness of
each dose will also be studied.